Informed-money record

MLTX · MoonLake Immunotherapeutics

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

3

Bearish filings

36

Named actors

12

Disclosed $ (bull / bear)

$99K / $145.7M

Recent disclosures

25 of 39 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-07-10Chief Executive Officer Santos da Silva Jorgesold$1.4MSEC ↗
2026-07-09Chief Executive Officer Santos da Silva Jorgesold$679KSEC ↗
2026-07-01Chief Executive Officer Santos da Silva Jorgesold$957KSEC ↗
2026-06-30Officer (via UBS Financial Services, Inc.) Santos da Silva Jorgefiled notice to sell$3.0MSEC ↗
2026-06-24Issuer (share issuance)priced an offeringSEC ↗
2026-06-22Issuer (share issuance)priced an offeringSEC ↗
2026-06-22Chief Financial Officer Bodenstedt Matthiassold$862KSEC ↗
2026-06-18Chief Financial Officer Bodenstedt Matthiassold$55KSEC ↗
2026-06-17Chief Scientific Officer Reich Kristiansold$972KSEC ↗
2026-06-17Chief Financial Officer Bodenstedt Matthiassold$297KSEC ↗
2026-06-16Chief Scientific Officer Reich Kristiansold$935KSEC ↗
2026-06-15Chief Scientific Officer Reich Kristiansold$945KSEC ↗
2026-06-15Officer (via UBS Financial Services, Inc.) Reich Kristianfiled notice to sell$2.9MSEC ↗
2026-05-11Chief Financial Officer Bodenstedt Matthiassold$273KSEC ↗
2026-04-14Chief Financial Officer Bodenstedt Matthiassold$47KSEC ↗
2026-04-13Chief Executive Officer Santos da Silva Jorgesold$946KSEC ↗
2026-04-10Chief Financial Officer Bodenstedt Matthiassold$38KSEC ↗
2026-04-10Chief Executive Officer Santos da Silva Jorgesold$1.8MSEC ↗
2026-04-10CEO (via UBS Financial Services Inc) Jorge Pedro Santos Radeck D Silvafiled notice to sell$2.8MSEC ↗
2026-04-09Chief Financial Officer Bodenstedt Matthiassold$1.6MSEC ↗
2026-04-09Officer (via UBS Financial Services, Inc.) Bodenstedt Matthiasfiled notice to sell$3.0MSEC ↗
2026-03-3110% Stockholder (via Goldman Sachs & Co. LLC) BVF PARTNERS L P/ILfiled notice to sell$63.5MSEC ↗
2026-03-31Chief Executive Officer and a director Dr. Jorge Santos da Silvaadopted a selling planSEC ↗
2026-03-10Chief Scientific Officer Dr. Kristian Reichadopted a selling planSEC ↗
2025-12-10Chief Financial Officer Mr. Matthias Bodenstedtterminated a selling planSEC ↗

14 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals